Some analysts predict the weekly injectable medication could become the best-selling drug of all time.   The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months. Zepbound is the latest entrant into the field of …

FDA approves weight loss drug from Eli Lilly that helped people lose up to 52 pounds Read More »

2023 was a strong year for innovative new drugs, with new medications for Alzheimer’s disease, weight loss, and the first treatment based on the gene-editing technology CRISPR. But 2024 is also shaping up to be a milestone year for some exciting therapies. Here’s what to expect. Another new Alzheimer’s drug Eli Lilly could debut a new treatment for Alzheimer’s …

Here Are the New Drugs and Treatments We Could See in 2024 Read More »

Pharmaceutical Technology outlines some of the biggest US Food and Drug Administration (FDA) drug approvals announced in 2023 that are set to make an impact in the coming years. Every year, the U.S. Food and Drug Administration (FDA) approves a wide range of new drugs and biological products. This year is no exception, with some …

Pharma breakthroughs: 10 novel drug approvals that made headlines in 2023 Read More »

Abstract Background: Delays in clinical trial enrollment and difficulties enrolling representative samples continue to vex sponsors, sites, and patient populations. Here we investigated use of an artificial intelligence-powered technology, Mendel.ai, as a means of overcoming bottlenecks and potential biases associated with standard patient prescreening processes in an oncology setting. Methods: Mendel.ai was applied retroactively to …

Improved screening using AI Read More »

Abstract Background: The cost of developing a new drug is approximately USD 2.6 billion, and over two-thirds of the total cost is embedded in the clinical-testing phase. Patient recruitment is the single biggest cause of clinical trial delays, and these delays can result in up to USD 8 million per day in lost revenue for pharmaceutical …

Virtual Clinical Trials Read More »

Brain Fog Caused by Long COVID and Chemo Appear Similar Data from mouse models for mild coronavirus infections and human tissue samples offer further evidence that it doesn’t take a severe infection—or even infection of brain cells at all—to cause long-term neurological symptoms. Read More